Grufity logo
Grufity logo

Latest TANG CAPITAL MANAGEMENT LLC Stock Portfolio

$2.20Billion | No. of Holdings #40

TANG CAPITAL MANAGEMENT LLC Performance

2026 Q2+13.94%
YTD+15.32%
2025+36.74%

About TANG CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings

On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, TANG CAPITAL MANAGEMENT LLC reported an equity portfolio of $2.2 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of TANG CAPITAL MANAGEMENT LLC are AUPH, AGLE, MIRM. The fund has invested 10.1% of it's portfolio in AURINIA PHARMACEUTICALS INC and 7.6% of portfolio in SPYRE THERAPEUTICS INC. <br><br> The fund managers got completely rid off KALVISTA PHARMACEUTICALS INC (KALV), JANUX THERAPEUTICS INC (JANX) and BIOGEN INC (BIIB) stocks. They significantly reduced their stock positions in INSMED INC (INSM), MODERNA INC (MRNA) and STOKE THERAPEUTICS INC (STOK). TANG CAPITAL MANAGEMENT LLC opened new stock positions in NUVECTIS PHARMA INC (NVCT), FULCRUM THERAPEUTICS INC (FULC) and NANO DIMENSION LTD (NNDM). The fund showed a lot of confidence in some stocks as they added substantially to TARSUS PHARMACEUTICALS INC (TARS), CELCUITY INC (CELC) and COMPASS PATHWAYS PLC (CMPS).
TANG CAPITAL MANAGEMENT LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$2.20Billion
  as of Aug 14, 2026

TANG CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500

Our best estimate is that TANG CAPITAL MANAGEMENT LLC made a return of 13.94% in the last quarter. In trailing 12 months, it's portfolio return was 65.28%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
nuvectis pharma inc28,504,500
fulcrum therapeutics inc23,868,400
nano dimension ltd20,724,600
gossamer bio inc11,468,400
boundless bio inc6,399,690
New stocks bought by TANG CAPITAL MANAGEMENT LLC

Additions

Ticker% Inc.
tarsus pharmaceuticals inc31.94
celcuity inc25.2
compass pathways plc24.93
capricor therapeutics inc20.59
compass therapeutics inc7.15
aurinia pharmaceuticals inc6.66
nuvation bio inc4.76
Additions to existing portfolio by TANG CAPITAL MANAGEMENT LLC

Reductions

Ticker% Reduced
insmed inc-61.54
moderna inc-50.00
stoke therapeutics inc-40.00
anaptysbio inc-33.33
state str spdr s&p 500 etf t-26.79
pliant therapeutics inc-0.03
TANG CAPITAL MANAGEMENT LLC reduced stake in above stock

Sold off

Ticker$ Sold
kalvista pharmaceuticals inc-92,065,200
coherus oncology inc-3,188,600
nkarta inc-3,124,540
fate therapeutics inc-1,401,330
kezar life sciences inc-4,929,210
arvinas inc-5,709,780
janux therapeutics inc-6,950,000
evolus inc-1,985,220
TANG CAPITAL MANAGEMENT LLC got rid off the above stocks

Sector Distribution

TANG CAPITAL MANAGEMENT LLC has about 74.7% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare74.7
Others25.3

Market Cap. Distribution

TANG CAPITAL MANAGEMENT LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • SMALL-CAP
  • MID-CAP
  • UNALLOCATED
  • MICRO-CAP
Category%
SMALL-CAP36.7
MID-CAP35
UNALLOCATED25.3
MICRO-CAP2.3

Stocks belong to which Index?

About 57.5% of the stocks held by TANG CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
Index%
RUSSELL 200057.5
Others42.3
Top 5 Winners (%)%
CMPS
compass pathways plc
121.4 %
CORT
corcept therapeutics inc
115.7 %
AGLE
spyre therapeutics inc
76.0 %
ANAB
anaptysbio inc
68.8 %
DERM
journey med corp
51.0 %
Top 5 Winners ($)$
AGLE
spyre therapeutics inc
72.5 M
CORT
corcept therapeutics inc
70.0 M
ANAB
anaptysbio inc
50.8 M
CMPS
compass pathways plc
38.8 M
kiniksa pharmaceuticals intl
35.7 M
Top 5 Losers (%)%
CMPX
compass therapeutics inc
-57.8 %
HRTX
heron therapeutics inc
-46.7 %
lenz therapeutics inc
-37.9 %
INSM
insmed inc
-24.1 %
WVE
wave life sciences ltd
-19.9 %
Top 5 Losers ($)$
CMPX
compass therapeutics inc
-53.9 M
CAPR
capricor therapeutics inc
-23.7 M
CELC
celcuity inc
-11.3 M
INSM
insmed inc
-10.2 M
TARS
tarsus pharmaceuticals inc
-9.9 M

TANG CAPITAL MANAGEMENT LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of TANG CAPITAL MANAGEMENT LLC

TANG CAPITAL MANAGEMENT LLC has 40 stocks in it's portfolio. About 62.7% of the portfolio is in top 10 stocks. CMPX proved to be the most loss making stock for the portfolio. AGLE was the most profitable stock for TANG CAPITAL MANAGEMENT LLC last quarter.

$2.20BTotal Value
56.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of TANG CAPITAL MANAGEMENT LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
AUPH
Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

AUPH
TANG CAPITAL MANAGEMENT LLC's holding in Aurinia Pharmaceuticals Inc over time
10.05%13,044,100
$221.36M
10.05%
increased 6.66 percentadded
BNTX
Biontech Se

Biontech Se

BNTX
TANG CAPITAL MANAGEMENT LLC's holding in Biontech Se over time
1.99%470,000
$43.73M
1.99%
unchanged 0 percentunchanged
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
TANG CAPITAL MANAGEMENT LLC's holding in Compass Pathways Plc over time
3.21%5,000,000
$70.75M
3.21%
increased 24.93 percentadded